ANAB

ANAPTYSBIO, INC

Biotechnology · Biotechnology

$320.24 sample

+5.08 (+1.61%) 1D

Market cap

$781.7B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-24

Alerts

8

Price$320.24 +8.38% 3M daily closessample

324.64288.27

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 24SEC10-Q filed
Sep 15INSInsider buy: 10% owner
Sep 09INSInsider buy: Director
Sep 02INSInsider sell: General Counsel
Aug 27SECForm 144 filed
Aug 19SECDEF 14A filed
Aug 12SEC10-Q filed
Aug 05SECForm 144 filed

Sign up to see the real ANAB record →

Company facts

SEC EDGAR registration

Name: ANAPTYSBIO, INC
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -47sample, -100 to +100
Reporting currency: USD

Who is positioning in ANAB

sample

Insiders: 26 insider transactions over 90 days, net selling, $369.5M
Congress: 5 members traded over 90 days
Institutions · 13F: 32 funds hold $17.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$27.8B +15.4% y/y

Q4 2024Q3 2026

Inventory$17.3B +18.5% y/y

Q4 2024Q3 2026

Accounts receivable$12.0B +3.6% y/y

Q4 2024Q3 2026

Total debt$32.3B +4.5% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $424.4B +2.6% 3M
Sample peer B: $467.4B +1.1% 3M
Sample peer C: $392.6B +8.3% 3M
Sample peer D: $273.6B -3.1% 3M
Sample peer E: $256.9B -6.3% 3M